Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05625360 · ClinicalTrials.gov registry record · Phase 3
REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss
A Phase 3 study of Anxiety and Sleep Disturbance, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 2
- Study locations
NCT05625360 is a Phase 3 study of Anxiety and Sleep Disturbance that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 160 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05625360, a Phase 3 study of Anxiety and Sleep Disturbance, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to learn how two different supportive programs may help women feel better after surgery. This study will measure if one type of supportive program is more useful than the other for improving wellbeing after surgery.
Conditions Studied
Interventions
- OTHER eHealth Mindful Movement and Breathing
- OTHER Life Impacts Reflection
- OTHER PROMIS Questionnaires
Study Locations (2)
North Carolina
- Atrium Health - Levine Cancer Institute - Charlotte
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-06-13 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05625360
The ClinicalTrials.gov registry entry for NCT05625360 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (64% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which eHealth Mindful Movement and Breathing is the first listed.
NCT05625360 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05625360 about?
NCT05625360 is a clinical study titled "REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss". The purpose of this research study is to learn how two different supportive programs may help women feel better after surgery. This study will measure if one type of supportive program is more useful than the other for improving wellbeing after surgery.
What is the current status of trial NCT05625360?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2023-06-13. Estimated completion is 2026-08-31.
What conditions does trial NCT05625360 study?
This clinical trial studies the following conditions: Anxiety, Sleep Disturbance, Malignant Female Reproductive System Neoplasm, Postoperative Pain, Acute, Postoperative Depression.
What interventions are being tested in trial NCT05625360?
The interventions under investigation include: eHealth Mindful Movement and Breathing (OTHER), Life Impacts Reflection (OTHER), PROMIS Questionnaires (OTHER).
Who is sponsoring clinical trial NCT05625360?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05625360 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 3
-
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
COMPLETED · Phase 3
-
A Study Comparing Two Treatments for Child With Anxiety
COMPLETED · Phase 3
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.